Abstract
Cyclophosphamide therapy for secondary amyloidosis in a patient with juvenile idiopathic arthritis unresponsive to tumor necrosis factor α inhibitor therapy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have